Ureaplasma – Not an STI

Ureaplasma sounds like something you’d want out of your body immediately.

And that instinct is exactly why it should not be included on routine STI panels.

Let’s walk through it.

⸻

What People Mean When They Say “Ureaplasma”

When people say “Ureaplasma,” they are referring to two species:

• Ureaplasma parvum
• Ureaplasma urealyticum

These are the only Ureaplasma species found in humans.

They are often grouped together on lab tests, but they are not identical:

• U. parvum is very common and usually harmless
• U. urealyticum is less common and sometimes associated with disease in specific situations

But here is the key:

Ureaplasma species, including both of these, are not recommended for routine STI screening.

⸻

Not Everything That Shows Up on a Test Is a Disease

Some organisms are clear sexually transmitted infections.

For example, Mycoplasma genitalium has a defined role in disease and is treated when identified.

Ureaplasma does not work that way.

A major review in Clinical Microbiology Reviews states:

“Ureaplasma spp. can be isolated from the lower urogenital tract of many healthy adults.”
(Sweeney et al., 2016)

And prevalence is high:

“Ureaplasma can be isolated from 40 percent to 80 percent of sexually active females.”
(Sweeney et al., 2016)

So in many cases, a positive result reflects colonization, not infection.

⸻

A Positive Result Does Not Mean You “Caught” Something

Ureaplasma can be transmitted through sexual contact.

But it is not exclusively sexually transmitted, and detection alone cannot determine how or when it was acquired.

Studies of genital microbiology, including organisms in the same family as Ureaplasma, have shown colonization in individuals without sexual exposure.¹

At the same time, colonization rates increase with sexual activity in adults.

Both are true.

And that leads to the key point:

A positive Ureaplasma result cannot tell you:

• When it was acquired
• Who it came from
• Whether it was sexually transmitted

This is one of the most misunderstood parts of this topic.

⸻

What Major Medical Organizations Actually Say

This is where the debate ends.

The Centers for Disease Control and Prevention states:

“No specific evidence exists for a role for Ureaplasma parvum or Ureaplasma urealyticum in cervicitis.”
“Testing for these organisms is not recommended.”
(CDC STI Treatment Guidelines, 2021)

A European STI guideline position statement notes:

“Routine testing and treatment of asymptomatic or symptomatic men and women for U. parvum and U. urealyticum are not recommended.”
(Horner et al., 2018)

And more directly:

“We have no evidence that we are doing more good than harm detecting and subsequently treating these organisms.”
(Horner et al., 2018)

⸻

The Important Nuance

The two species are not identical.

• Ureaplasma parvum
• Most common
• Frequently found in healthy individuals
• Weak or no consistent link to disease
• Ureaplasma urealyticum
• Less common
• Sometimes associated with nongonococcal urethritis in men
• Still controversial

A review summarizes it clearly:

“U. parvum is more commonly detected in asymptomatic individuals, whereas U. urealyticum has been more frequently associated with disease in some settings.”
(Beeton et al., 2019)

But this does not change the guidelines.

Neither should be routinely tested for.

⸻

Why Ureaplasma Shows Up on STI Panels Anyway

Because it can be detected, and because more results can look like better care.

Some companies use expanded panels as a form of differentiation.

You will see language like:

“We offer a 21-panel test that includes things never tested for by others.”

That sounds comprehensive. It sounds advanced.

But more testing is not always better testing.

In fact, major guidelines warn that expanding panels to include organisms like Ureaplasma can lead to harm:

“The extensive testing, detection and subsequent antimicrobial treatment may result in selection of antimicrobial resistance and unnecessary costs.”
(Horner et al., 2018)

So patients receive a result that looks meaningful.

But often is not actionable.

And that distinction matters.

⸻

Can Ureaplasma Cause Problems

Ureaplasma has been associated with:

• Nongonococcal urethritis in men
• Pregnancy related complications

But association is not the same as causation.

And critically:

“Persistent detection was common but was not associated with persistent urethritis.”
(Khosropour et al., 2015)

Meaning the bacteria can remain even after symptoms resolve.

So treating until the test is negative is not evidence based care.

⸻

The Real Problem: Bad Testing Leads to Bad Decisions

Most STI tests are qualitative.

• Detected
• Not detected

That works for infections where any presence matters.

But for Ureaplasma:

Presence alone often does not tell you if anything is wrong.

So what happens:

• Positive result
• Antibiotics
• Repeat testing
• More antibiotics

And as guidelines state:

“Eradication is difficult and not strongly associated with cure.”
(Horner et al., 2018)

⸻

If Ureaplasma Is Tested At All

There are situations where a clinician may decide to evaluate Ureaplasma as part of a broader workup, particularly in patients with persistent or unexplained symptoms.

And this is where the distinction matters.

This is not the kind of test that can be interpreted in isolation.

When physicians choose to explore Ureaplasma, they are not relying on a simple positive or negative result alone. They are incorporating:

• The patient’s symptoms
• The clinical history
• Testing that goes beyond simple detection and, in some settings, may provide additional information such as organism burden
• Other test results
• Whether more established causes have already been ruled out

In some cases, additional factors such as species type or organism burden may be considered as part of that broader clinical picture.

That is fundamentally different from how Ureaplasma is used in consumer testing panels.

Because a panel provides a binary result, without context.

And without that context, the result often does not answer the question the patient is actually asking, which is:

👉 Is this what’s causing my symptoms?

That is a clinical judgment.

Not a lab result.

Ureaplasma is not a diagnosis. At best, it is a data point.

⸻

If You’re Dealing With Persistent Symptoms

If you are dealing with persistent, frustrating symptoms such as discharge, irritation, or recurrent BV, and you feel like you are not getting answers, this part matters.

It is very common to feel like something is being missed.

And when you finally see a positive result for Ureaplasma, it can feel like this is the missing piece.

This article is not here to dismiss what you are feeling or what you have been going through.

Those symptoms are real. The frustration is real. And the experience of not being heard in healthcare is, unfortunately, also real.

What this article is meant to do is add context.

Because the presence of Ureaplasma, especially Ureaplasma parvum, which is very common, does not necessarily explain those symptoms, even if it shows up on a test.

And in many cases, focusing on it can delay getting to the real cause.

That is why major medical guidelines recommend focusing first on well established, treatable conditions like bacterial vaginosis, yeast infections, and other causes of vaginal symptoms where treatment has been clearly shown to help.

You are not wrong to keep asking questions.

But not every positive test is an answer.

If a result feels like an answer, but does not lead to a clear, evidence based treatment that improves outcomes, it probably is not the answer.

⸻

Why We Don’t Include Ureaplasma in STI Panels

At Shameless Care, we follow evidence based guidelines.

And the consensus is clear:

• Ureaplasma species are commonly present in healthy people
• Detection does not equal disease
• Routine testing leads to more harm than benefit

So we do not include it.

Because a test should only exist if it leads to a clear, evidence based action.

If it does not, it is not healthcare.

It is noise.

⸻

References

1. Hammerschlag MR, Alpert S, Rosner I, et al. Microbiology of the vagina in children: normal and potentially pathogenic organisms. Pediatrics. 1978;62(1):57-62. https://pubmed.ncbi.nlm.nih.gov/98750/
2. Sweeney EL, Dando SJ, Kallapur SG, Knox CL. The human Ureaplasma species as causative agents of chorioamnionitis. Clinical Microbiology Reviews. 2016;30(1):349-379. https://pmc.ncbi.nlm.nih.gov/articles/PMC5217797/
3. Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines. 2021. https://www.cdc.gov/std/treatment-guidelines/urethritis-and-cervicitis.htm
4. Horner PJ, Donders G, Cusini M, Gomberg M, Jensen JS. Should we be testing for urogenital Mycoplasma hominis and Ureaplasma spp.? Journal of the European Academy of Dermatology and Venereology. 2018. https://iusti.org/wp-content/uploads/2019/12/UrogenitalMycoplasmas.pdf
5. Beeton ML, Payne MS, Jones L. The role of Ureaplasma spp. in nongonococcal urethritis. Frontiers in Public Health. 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6750135/
6. Khosropour CM, Manhart LE, Colombara DV, et al. Efficacy of standard therapies against Ureaplasma species and persistence among men with nongonococcal urethritis. Clinical Infectious Diseases. 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4509962/